مقالوصول مفتوح20261استشهاد· Semantic Scholar
GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
Frontiers in Aging Neuroscience · مجلد 18
GLP-1 receptor agonistsParkinson's diseaseAlzheimer's diseasedisease-modifying therapy
